TBK1 antibody (AA 539-588)
Quick Overview for TBK1 antibody (AA 539-588) (ABIN6747170)
Target
See all TBK1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 539-588
-
Brand
- IHC-plus™
-
Specificity
- Human TBK1
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human, Mouse, Rat, Dog, Bovine, Rabbit, Horse, Pig (100%) Chicken, Zebrafish (92%) Xenopus (85%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa539-588 of human TBK1 (Q9UHD2, NP_037386). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Galago, Marmoset, Mouse, Rat, Elephant, Panda, Dog, Bovine, Rabbit, Horse, Pig, Guinea pig, Platypus (100%), Zebra finch, Chicken, Lizard, Stickleback, Zebrafish (92%), Bat, Turkey, Xenopus (85%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: IHC, IHC-P (5 μg/mL), WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:312500. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- TBK1 (TANK-Binding Kinase 1 (TBK1))
-
Alternative Name
- NAK / TBK1
-
Background
-
Name/Gene ID: TBK1
Subfamily: IKAPPAB
Family: Protein Kinase
Synonyms: TBK1, T2K, NAK, NF-kappa-B-activating kinase, NF-kB-activating kinase, TANK-binding kinase 1 -
Gene ID
- 29110
-
NCBI Accession
- NP_037386
-
UniProt
- Q9UHD2
-
Pathways
- TLR Signaling, Activation of Innate immune Response, Hepatitis C, Toll-Like Receptors Cascades, SARS-CoV-2 Protein Interactome
Target
-